- Home
- HROW vs STAA Comparison
HROW vs STAA Comparison
Compare HROW & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- STAA
- Stock Information
- Founded
- HROW 1998
- STAA 1982
- Country
- HROW United States
- STAA United States
- Employees
- HROW N/A
- STAA N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- HROW Health Care
- STAA Health Care
- Exchange
- HROW Nasdaq
- STAA Nasdaq
- Market Cap
- HROW 1.4B
- STAA 1.4B
- IPO Year
- HROW N/A
- STAA N/A
- Fundamental
- Price
- HROW $43.15
- STAA $27.16
- Analyst Decision
- HROW Strong Buy
- STAA Hold
- Analyst Count
- HROW 7
- STAA 8
- Target Price
- HROW $64.67
- STAA $22.50
- AVG Volume (30 Days)
- HROW 506.9K
- STAA 674.6K
- Earning Date
- HROW 11-12-2025
- STAA 10-29-2025
- Dividend Yield
- HROW N/A
- STAA N/A
- EPS Growth
- HROW N/A
- STAA N/A
- EPS
- HROW N/A
- STAA N/A
- Revenue
- HROW $227,661,000.00
- STAA $224,449,000.00
- Revenue This Year
- HROW $45.86
- STAA N/A
- Revenue Next Year
- HROW $41.41
- STAA $27.24
- P/E Ratio
- HROW N/A
- STAA N/A
- Revenue Growth
- HROW 47.69
- STAA N/A
- 52 Week Low
- HROW $20.85
- STAA $13.50
- 52 Week High
- HROW $59.23
- STAA $38.60
- Technical
- Relative Strength Index (RSI)
- HROW 69.90
- STAA 56.69
- Support Level
- HROW $38.47
- STAA $27.52
- Resistance Level
- HROW $44.07
- STAA $28.13
- Average True Range (ATR)
- HROW 1.71
- STAA 0.48
- MACD
- HROW 0.38
- STAA -0.35
- Stochastic Oscillator
- HROW 89.11
- STAA 12.86
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.